School of Medicine


Showing 1,661-1,680 of 4,925 Results

  • Seunggu Jude Han, MD

    Seunggu Jude Han, MD

    Clinical Associate Professor, Neurosurgery

    BioDr. Han is a board-certified neurosurgeon with fellowship training in neuro-oncology. He is also a clinical associate professor in the Department of Neurosurgery at Stanford University School of Medicine and chief of neurosurgery at Palo Alto VA Medical Center.

    Dr. Han diagnoses and treats a wide range of conditions, including brain tumors, pituitary tumors, spinal tumors, and degenerative spinal disorders. He is passionate about caring for underserved populations, as well as educating and mentoring the next generation of neurosurgeons.

    Dr. Han’s academic and research interests include brain mapping, advancing diagnostic methods and treatments for brain tumors, and improving the quality of neurosurgical care. He has conducted several clinical trials to determine the safety and effectiveness of specific treatments for different tumors affecting the central nervous system.

    Dr. Han has published over 100 peer-reviewed articles in prestigious journals, including Neurology, Neurosurgery, Neuro-Oncology, and the Journal of Neurosurgery. He also serves as a reviewer for many professional publications.

    Dr. Han is a member of the American Association of Neurological Surgeons, the Congress of Neurological Surgeons, and the Society for Neuro-Oncology. He serves as an executive committee member and abstract reviewer for annual conferences in several of these organizations.

  • Summer Han

    Summer Han

    Associate Professor (Research) of Neurosurgery, of Medicine (Biomedical Informatics) and, by courtesy, of Epidemiology and Population Health

    Current Research and Scholarly InterestsMy current research focuses on understanding the genetic and environmental etiology of complex disease and developing and evaluating efficient screening strategies based on etiological understanding. The areas of my research interests include statistical genetics, molecular epidemiology, cancer screening, health policy modeling, and risk prediction modeling. I have developed various statistical methods to analyze high-dimensional data to identify genetic and environmental risk factors and their interactions for complex disease.

  • Philip C. Hanawalt

    Philip C. Hanawalt

    Dr. Morris Herzstein Professor in Biology, Emeritus

    Current Research and Scholarly InterestsMy current interest includes two principal areas:

    1. The molecular basis for diseases in which the pathway of transcription-coupled DNA repair is defective, including Cockyne syndrome (CS) and UV-sensitive syndrome (UVSS). Patients are severely sensitive to sunlight but get no cancers. See Hanawalt & Spivak, 2008, for review.

    2. Transcription arrest by guanine-rich DNA sequences and non-canonical secondary structures. Transcription collisions with replication forks.

  • Steven Hancock, MD

    Steven Hancock, MD

    Professor of Radiation Oncology (Radiation Therapy), Emeritus

    Current Research and Scholarly InterestsOutcomes of radiation treatment for prostate cancer. Clinical research interests in the late effects of radiation on normal tissues and chemical modification of radiation injury. Hodgkins's disease and late effects of radiation and combined modality therapy. Radiation sensitizers. Hypoxic cell cytotoxins. Esophageal cancers.
    General adult and pediatric radiation therapy.

  • Frank Hanley

    Frank Hanley

    Lawrence Crowley, M.D., Endowed Professor of Child Health

    Current Research and Scholarly InterestsHis research and clinical work focuses on the development of interventional techniques for fetal and neonatal treatment of congenital heart disease, pulmonary, vascular physiology, and the neurologic impact of open-heart surgery. He developed and pioneered the “unifocalization” procedure, in which a single procedure is used to repair a complex and life-threatening congenital heart defect rather than several staged open-heart surgeries as performed by other surgeons.

  • Maha Hanna

    Maha Hanna

    Clinical Assistant Professor, Pediatrics

    Current Research and Scholarly InterestsA bad latch means maternal excruciating pain, ineffective milk transfer with subsequent weight loss, hypoglycemia, higher risk of hyperbilirubinemia and dehydration fever.All of the above led to early cessation of breastfeeding; 46% of mothers who initiate exclusive breastfeeding stop within the first 12 weeks because of difficult latch. I developed a latch tutorial focusing on step-by step-in striations for achieving an effective, non-painful latch.

  • Josef Hannah

    Josef Hannah

    Clinical Assistant Professor, Medicine - Primary Care and Population Health

    BioDr. Hannah graduated from Kansas City University of Medicine & Biosciences. He then completed a residency in Internal Medicine at the University of Kansas and a fellowship in Hospice & Palliative Medicine at Stanford University before joining as faculty at Stanford. His clinical practice includes both inpatient palliative care consultation as well as ambulatory care in palliative medicine. His research and educational interests include symptom management and utilizing media to grow palliative care services and education.

  • Sigurdis Haraldsdottir

    Sigurdis Haraldsdottir

    Member, Stanford Cancer Institute

    BioDr. Sigurdis Haraldsdottir, M.D., Ph.D. is an Assistant Professor of Medicine at Stanford University School of Medicine. She received her medical degree and master's degree in medical sciences from the University of Iceland. She did her Internal Medicine training at Boston University Medical Center and training in Medical Oncology at the Ohio State University, before joining the faculty at Stanford. Her clinical and research focus is in gastrointestinal malignancies with a focus on mismatch repair deficient cancers, particularly colorectal cancer. She is conducting population-based research on Lynch syndrome - an inherited cancer syndrome, and recently completed a nation-wide study on Lynch syndrome in Iceland. She received her Ph.D. in Medical Sciences in 2017 from the University of Iceland. Her interests also focus on investigating colorectal cancer genomics, and their effect on outcomes and treatment implications.

  • Pehr Harbury

    Pehr Harbury

    Associate Professor of Biochemistry

    Current Research and Scholarly InterestsScientific breakthroughs often come on the heels of technological advances; advances that expose hidden truths of nature, and provide tools for engineering the world around us. Examples include the telescope (heliocentrism), the Michelson interferometer (relativity) and recombinant DNA (molecular evolution). Our lab explores innovative experimental approaches to problems in molecular biochemistry, focusing on technologies with the potential for broad impact.

  • Antonio Hardan, M.D.

    Antonio Hardan, M.D.

    Professor of Psychiatry and Behavioral Sciences

    Current Research and Scholarly InterestsThe neurobiology of autism
    Neuroimaging in individuals with autism
    Psychopharmacological treatment of children and adults with autism and/or developmental disorders
    The neurobiology and innovative interventions of several neurogenic disorders including DiGeorge Syndrome (Velocardiofacial syndrome; 22q11.2 mutations), PTEN mutations, and Phelan McDermid Syndrome (22q13 mutations).

  • Kate Hardy

    Kate Hardy

    Clinical Professor, Psychiatry and Behavioral Sciences

    BioKate Hardy is a California Licensed Psychologist who has specialized in working with individuals with psychosis for over 20 years in both research and clinical settings. Dr. Hardy received her doctorate in clinical psychology from the University of Liverpool, United Kingdom. She has worked in specialist early psychosis services in both the UK and the US, including UCSF’s Prodrome Assessment Research and Treatment (PART) program, where she completed her post-doctoral fellowship, and as Clinical Director for the Prevention and Recovery from Early Psychosis (PREP) program. Dr. Hardy is the co-director for the INSPIRE clinic at the Department of Psychiatry and Behavioral Health, Stanford University and has significant experience in providing CBTp to individuals with early psychosis, and those at risk of developing psychosis, in both individual and group settings and integration of this clinical intervention to broader systems and staff teams. Dr. Hardy is also involved in the implementation of national strategies to increase dissemination of early psychosis models with the aim of bringing these cutting edge treatments to a broader population and is the co-editor of the book Intervening Early: A team approach.

    Dr. Hardy is also the director of INSPIRE training and within this role has led multiple trainings and workshops in CBTp to a wide variety of audiences including community clinicians, psychiatrists, and families, and provides ongoing supervision and consultation in this approach. INSPIRE training offers training in evidence based interventions for psychosis to providers across diverse settings. In 2024 Dr. Hardy became president elect for IEPA: Intervening Early in Mental Health.

  • Brian A. Hargreaves

    Brian A. Hargreaves

    Professor of Radiology (Radiological Sciences Laboratory) and, by courtesy, of Electrical Engineering and of Bioengineering

    Current Research and Scholarly InterestsI am interested in magnetic resonance imaging (MRI) applications and augmented reality applications in medicine. These include abdominal, breast and musculoskeletal imaging, which require development of faster, quantitative, and more efficient MRI methods that provide improved diagnostic contrast compared with current methods. My work includes novel excitation schemes, efficient imaging methods and reconstruction tools and augmented reality in medicine.